Edwards Lifesciences Corporation

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation, headquartered in Irvine, California, designs, manufactures, and markets medical devices for structural heart disease and critical care monitoring. Founded in 1958 and publicly traded on NYSE:EW, the company pioneered transcatheter aortic valve replacement and offers surgical heart valves, hemodynamic monitoring systems, and advanced catheter-based technologies. Its products serve hospitals and clinicians in more than 100 countries, focusing on improving patient outcomes in cardiovascular care.